Sana Biotechnology, Inc. Insider Trading
SANA
No open-market buying or selling by insiders.
The last open-market buy by an executive or director was in Feb 2024.
Get an email when SANA's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Jan 8, 2025 | FMR LLC Large holder | SoldNo plan 4 parts | 290,912 | $6.49 average | $1.89M | 6.0% | Form 4 |
- Jan 8, 2025No planFMR LLCLarge holder · sold 290,912 at avg $6.49$1.89M6.0% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Peers
Biological Products, (No Diagnostic Substances) · Pick stocks to compare with SANA
Held by ETFs
SANA is in 18 US ETFs. The largest of them, with SANA's weight in each:
Vanguard Health Care ETFVHT0.01%of the fund
iShares Russell 2000 Growth ETFIWO0.03%of the fund
Fidelity Nasdaq Composite Index ETFONEQ0.00%of the fund
State Street SPDR S&P Biotech ETFXBI0.14%of the fund
iShares Biotechnology ETFIBB0.03%of the fund
iShares U.S. Small-Cap Equity Factor ETFSMLF0.04%of the fund
Spot a number that looks wrong? Check it in SANA's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing SANA
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.